Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026)
Achieve Life Sciences' (ACHV) quarterly Goodwill & Intangibles came in at $1.7 million in Q1 2026, down 11.37% YoY from $2.0 million in Q1 2025, and down 3.08% on a QoQ basis from $1.8 million in Q4 2025.
Analysis
Achieve Life Sciences (ACHV) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 11 years of Goodwill & Intangibles data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 11.37% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.37% YoY) and the FY2025 annual result came in at $1.8 million, down 11.11% from the prior year.
- Goodwill & Intangibles eased to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $2.6 million in Q1 2022 to a low of $1.7 million in Q1 2026.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Goodwill & Intangibles.
- The widest YoY moves for Goodwill & Intangibles: up 7.84% in 2022, down 38.23% in 2022.
- Tracing ACHV's Goodwill & Intangibles over 5 years: stood at $2.5 million in 2022, then retreated by 9.01% to $2.2 million in 2023, then decreased by 10.0% to $2.0 million in 2024, then retreated by 11.11% to $1.8 million in 2025, then declined by 3.08% to $1.7 million in 2026.
- The last three Goodwill & Intangibles figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | 2.29 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.73 Mn |